Subscribe

Archive | X-Change Corp

XCHC to Launch its New Website at 11:00am PDT Today, Critical Ailment Information, Patient Tracking Resources, Cannabinoid Research Platforms, and Patient-to-Patient Information Exchange

phytiva

DALLAS, May 15, 2013 /PRNewswire/ — X-Change Corp. (NASDAQ OTC: XCHC), a U.S. Company specializing in cannabinoid formulation-based health solutions through its Phytiva brand product lines is excited to announce at 11:00am PDT the launch of its new website at www.phytiva.com.  The team has been working to create a website that provides self-medicated cannabinoid patients with an […]

XCHC Issues Weighted Performance Guidance for New Product Releases, Operational Expansion, and Corporate Developments

phytiva

AMSTERDAM, May 6, 2013 /PRNewswire/ — X-Change Corp (NASDAQ OTC: XCHC), a U.S. Company specializing in cannabinoid formulation-based health solutions, is pleased to provide a weighted performance guidance report for Company shareholders and its patient-oriented interested parties. Chad S. Johnson, Esq., Chief Operating Officer and General Counsel of X-Change Corp, stated “The Company has gone through […]

Famed County Singer Greta Gaines Appointed to Board of Advisors of The X-Change Corporation in Further Preparations for the Initial Phytiva Product Launch

gretagains

DALLAS, April 12, 2013 / TheNewswire / — X-Change Corp. (NASDAQ OTC: XCHC), a U.S. Company specializing in cannabinoid formulation based health and wellness solutions, is proud to announce the appointment of Greta Gaines to its Board of Advisors. A noted Country singer and songwriter, Ms. Gaines will bring instrumental exposure for Phytiva branding, marketing, […]

XCHC Announces Initial Planning and Development of Cannabis Medical Treatment Centers to Open in Colorado, California, and Other Friendly Markets Across the Globe

phytiva

DALLAS, March 6, 2013 /PRNewswire/ — X-Change Corp. (NASDAQ OTC: XCHC), a U.S. Company specializing in cannabinoid formulation-based health solutions through its Phytiva brand product lines announces, plans to develop and open cannabis medical treatment centers in Colorado, California, and other U.S. and international markets where existing law permits. X-Change Corporation is proud to announce the […]

XCHC President & CEO, Robert Kane, Issues Cannabinoid Financial Industry Insight and Illustrates Possible Economic Impact to US Economy at Executive Breakfast

phytiva

DALLAS, Feb. 28, 2013 /PRNewswire/ — X-Change Corp. (NASDAQ OTC: XCHC), a U.S. company specializing in cannabis and hemp based extracts.  The Company is focused on introducing consumer product lines that target medical cannabinoids, cosmeceutical, nutraceutical, and social usage solutions through multiple Phytiva Brand product lines, products, and services.  Earlier this week, Robert Kane addressed business […]

XCHC Signs Historic Agreement with Maliseet Nation to Allow Medical Cannabis Hospitals

CannabisScience

DALLAS, Feb. 13, 2013 /PRNewswire/ — The X-Change Corporation (NASDAQ OTC: XCHC) (X-Change Corp. or the Company), a U.S. boutique company whose niche is cannabis and hemp based extracts and products that target medical cannabis, cosmeceutical, nutraceutical, and social usage solutions through multiple Phytiva Brand product lines and solutions, is proud to announce it has entered […]

Cannabis Science Appoints Harold C. Smith, Ph.D to Scientific Advisory Board

CannabisScience

COLORADO SPRINGS, Colo., Feb. 12, 2013 /PRNewswire/ — Cannabis Science, Inc. (NASDAQ OTC: CBIS) has appointed Harold C. Smith, Ph.D., Professor in Biochemistry, Biophysics, and Oncology with secondary appointments as Professor in the Department of Genetics and Pathology and a Member of the Center for RNA Biology at the University of Rochester, School of Dentistry and […]

Cannabis Science Inc. Releases Corporate Operational Guidance for 2013

CannabisScience

COLORADO SPRINGS, Colo., Jan. 31, 2013 /PRNewswire/ — Cannabis Science, Inc. (NASD OTC: CBIS) announced today itsCorporate Operational Guidance for 2013, highlighting a strategic action plan to “bring to market” innovative, cannabinoid-based, life-saving, anti-cancer drugs.  The Company anticipates releasing a variety of cannabinoid-based treatments that already show great promise in fighting HIV-related illnesses like Kaposi’s […]

X-Change Corp. Quickly Advances To Testing Stage With Its ‘Phytiva’ Brand Of Products

phytiva

DALLAS, Jan. 31, 2013 /PRNewswire/ – X-Change Corporation (NASDAQ OTC: XCHC), a U.S. publicly-traded company, through its European joint venture with Dupetit Natural Products, GmbH, announces that within one week the Company will move into the testing stage of development of its unique hemp-based Phytiva brand of products, as the Company prepares to bring these products […]

X-Change Corp Appoints Drue Young as Vice President of Product Development; First Television Campaign for Phytiva Brand Line of Products is Scheduled for the First Quarter of 2013

phytiva

DALLAS, Jan. 9, 2013 /PRNewswire/ — X-Change Corp (NASDAQ OTC: XCHC), a U.S. boutique company whose niche is extract-based cosmeceutical and nutraceutical solutions through its Phytiva brand product line, announced today that Drue Young has been named Vice President of Product Development. Mr. Young’s experience as creative director and a designer for high-profile companies and clients […]